Pegram M - Search Results

1

Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents.

Holash J, Thurston G, Rudge JS, Yancopoulos GD, Adjei AA, Bergers G, Pytowski B, Pegram M, Gordon MS. Holash J, et al. Among authors: pegram m. Cancer Metastasis Rev. 2006 Jun;25(2):243-52. doi: 10.1007/s10555-006-8504-6. Cancer Metastasis Rev. 2006. PMID: 16770536 Review. No abstract available.

2

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status.

Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Gordon MS, et al. Among authors: pegram md. J Clin Oncol. 2006 Sep 10;24(26):4324-32. doi: 10.1200/JCO.2005.05.4221. Epub 2006 Aug 8. J Clin Oncol. 2006. PMID: 16896006 Clinical Trial.

3

Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.

Jerome L, Alami N, Belanger S, Page V, Yu Q, Paterson J, Shiry L, Pegram M, Leyland-Jones B. Jerome L, et al. Among authors: pegram m. Cancer Res. 2006 Jul 15;66(14):7245-52. doi: 10.1158/0008-5472.CAN-05-3555. Cancer Res. 2006. PMID: 16849573

4

Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy.

Taylor C, Hershman D, Shah N, Suciu-Foca N, Petrylak DP, Taub R, Vahdat L, Cheng B, Pegram M, Knutson KL, Clynes R. Taylor C, et al. Among authors: pegram m. Clin Cancer Res. 2007 Sep 1;13(17):5133-43. doi: 10.1158/1078-0432.CCR-07-0507. Clin Cancer Res. 2007. PMID: 17785568

5

Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy.

Pal SK, Pegram M. Pal SK, et al. Among authors: pegram m. Anticancer Drugs. 2005 Jun;16(5):483-94. doi: 10.1097/00001813-200506000-00003. Anticancer Drugs. 2005. PMID: 15846113 Review.

6

Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).

Abraham J, Coleman R, Elias A, Holmes FA, Kalinsky K, Kittaneh M, Lower E, Mahtani R, Terry Mamounas E, Pegram M, Vogel C; Breast Cancer Therapy Expert Group (BCTEG). Abraham J, et al. Among authors: pegram m. Breast Cancer Res Treat. 2018 Aug;171(1):11-20. doi: 10.1007/s10549-018-4783-1. Epub 2018 May 4. Breast Cancer Res Treat. 2018. PMID: 29725889 Review.

7

Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor.

Pegram MD, Reese DM. Pegram MD, et al. Semin Oncol. 2002 Jun;29(3 Suppl 11):29-37. doi: 10.1053/sonc.2002.34053. Semin Oncol. 2002. PMID: 12138395 Review.

8

Can we circumvent resistance to ErbB2-targeted agents by targeting novel pathways?

Pegram M. Pegram M. Clin Breast Cancer. 2008 Mar;8 Suppl 3:S121-30. doi: 10.3816/cbc.2008.s.008. Clin Breast Cancer. 2008. PMID: 18777951 Review.

9

Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.

Konecny GE, Pegram MD, Venkatesan N, Finn R, Yang G, Rahmeh M, Untch M, Rusnak DW, Spehar G, Mullin RJ, Keith BR, Gilmer TM, Berger M, Podratz KC, Slamon DJ. Konecny GE, et al. Among authors: pegram md. Cancer Res. 2006 Feb 1;66(3):1630-9. doi: 10.1158/0008-5472.CAN-05-1182. Cancer Res. 2006. PMID: 16452222

10

Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.

Albain KS, Carey L, Gradishar WJ, Gralow JR, Lipton A, Rugo H, Tripathy D, Peck S, Abair T, Pegram M. Albain KS, et al. Among authors: pegram m. Clin Breast Cancer. 2010 Dec 1;10(6):421-39. doi: 10.3816/CBC.2010.n.056. Clin Breast Cancer. 2010. PMID: 21147685 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters